Airway remodeling in asthma: Mechanisms and therapeutical perspectives;Le remodelage bronchique dans l'asthme: Mécanismes et enjeux thérapeutiques

Medecine/Sciences

Volumn 19, Issue 3, 2003, Pages 319-326

  Benayoun, Laurent ^a   Pretolani, Marina ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; MATRIX METALLOPROTEINASE;

ASTHMA; CLINICAL FEATURE; HISTOPATHOLOGY; HUMAN; LUNG BIOPSY; LUNG FUNCTION; REVIEW; RISK FACTOR;

EID: 0037341190     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.1051/medsci/2003193319     Document Type: Review

References (44)

1. Gergen PJ. Understanding the economic burden of asthma. J Allergy Clin Immunol 2001; 107: S445-8.
2. Neukirch F, Pin I, Knani J, et al. Prevalence of asthma and asthma-like symptoms in three French cities. Respir Med 1995; 89: 685-92.
3. Guidelines for the Diagnosis and Management of Asthma. Expert Panareport 2. Atlanta, Ga: National Institute of Health, May 1997. National Heart, Lung and Blood Institute Publication n° 97-4051A.
4. Djukanovic R, Roche WR, Wilson JW, Beasley CRW, Twentyman OP, Howarth PH. Mucosal inflammation in asthma. Am Rev Respir Dis 1990; 142: 434-57.
5. Barnes PJ. Mechanisms of action of glucocorticoids in asthma. Am J Respir Crit Care Med 1996; 154: 21-7.
6. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998; 339: 1194-200.
7. Chung KF, Godard P. ERS task force: difficult therapy-resistant asthma. Eur Respir J 1999; 13: 1198-208.
8. Elias JA, Zhu Z, Chupp G, Hamer RJ. Airway remodeling in asthma. J Clin Invest 1999; 104: 1001-6.
9. Bousquet J, Jeffery P, Busse WW, Johnson M, Vignola AM. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000; 161: 1720-45.
10. Barnes PJ. Chronic obstructive pulmonary disease. N Engl J Med 2000; 343: 269-80.
11. Jeffery PK. Remodeling in asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: S28-38.
12. Vignola AM, Chiappara G, Gagliardo R, et al. Apoptosis and airway inflammation in asthma. Apoptosis 2000; 5: 473-85.
13. Druilhe A, Létuvé S, Pretolani M. Eosinophil apoptosis in asthma. Pathol Biol 2000; 48: 566-73.
14. Pretolani M. Remodeling of the respiratory tract in asthma. Biological factors and potential physiopathological implications in the apoptosis process. Rev Mal Respir 1999; 16: S27-8.
15. Anderson JM. Molecular structure of tight junctions and their role in epithelial transport. News Physiol Sci 2001; 16: 126-30.
16. Nievers MG, Schaapveld RQ, Sonnenberg A. Biology and function of hemidesmosomes. Matrix Biol 1999; 18: 5-17.
17. Holgate ST, Davies DE, Lackie PM, Wilson SJ, Puddicombe SM, Lordan JL. Epithelial-mesenchymal interactions in the pathogenesis of asthma. Eur Respir J 2000; 105: 193-204.
18. Davies DE, Polosa R, Puddicombe SM, Richter A, Holgate ST. The epidermal growth factor receptor and its ligand family: their potential role in repair and remodelling in asthma. Allergy 1999; 54: 771-83.
19. Thompson AB, Robbins RA, Romberger DJ, et al. Immunological functions of the pulmonary epithelium. Eur Respir J 1995; 8: 127-49
20. Waters CM, Savla U. Keratinocyte growth factor accelerates wound closure in airway epithelium during cyclic mechanical strain. J Cell Physiol 1999; 181: 424-32.
21. Takeoka M, Word WF, Pollack H, Kamp DW, Panos RJ. KGF facilitates repair of radiation-induced DNA damage in alveolar epithelial cells. Am J Physiol 1997; 272: L1174-80.
22. Okada-Ban M, Thiery JP, Jouanneau J. Fibroblast growth factor-2. Int J Biochem Cell Biol 2000; 32: 263-7.
23. Carpenter G, Wahl MI. The epidermal growth factor family. In: Sporn MB, Roberts AB, eds. Peptide growth factors and their receptors. New York: Springer-Verlag, 1991: 69-171.
24. Puddicombe SM, Polosa R, Richter A, et al. Involvement of the epidermal growth factor receptor in elpithelial repair in asthma. FASEB J 2000; 14: 1362-74.
25. Warburton D, Schwarz M, Tefft D, Flores-Delgado G, Anderson KD, Cardoso WV. The molecular basis of lung morphogenesis. Mech Dev 2000; 92: 55-81.
26. Johnson P, Maiti A, Brown KL, Li R. A role for the cell adhesion molecule CD44 and sulfation in leukocyte-endothelial cell adhesion during an inflammatory response? Biochem Pharmacol 2000; 59: 455-65.
27. Ilyas M, Tomlison IP. The interactions of APC, E-cadherin and β-catenin in tumour development and progression. J Pathol 1997; 182: 128-37.
28. Kikuchi A. Regulation of catenin signaling in the Wnt pathway. Biochem Biophys Res Commun 2000; 268: 243-8.
29. Stockinger A, Eger A, Wolf J, Beug H, Foisner R. E-cadherin regulates cell growth by modulating proliferation-dependent β-catenin transcriptional activity. J Cell Biol 2001; 154: 1185-96.
30. Goto Y, Uchida Y, Nomura A, et al. Dislocation of E-cadherin in the airways epithelium during an antigen-induced asthmatic response. Am J Respir Cell Mol Biol 2000; 23: 712-8.
31. Carayol N, Campbell A, Vachier I, et al. Modulation of cadherin and catenin expression by tumor necrosis factor-α and dexamethasone in human bronchial epithelial cells. Am J Respir Cell Mol Biol 2002; 26: 341-7.
32. Hirst SJ, Walker TR, Chilvers ER. Phenotypic diversity and molecular mechanisms of airway smooth proliferation in asthma. Eur Respir J 2000; 16: 159-77.
33. Aikawa M, Palanisamy NS, Kuro-o N, et al. Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis. Circ Res 1993; 73: 1000-12.
34. Liu X, Shoo Q, Dhalla NS. Myosin light chain phosphorylation in cardiac hypertrophy and failure due to myocardial infarction. J Mol Cell Cardiol 1995; 27: 2613-21.
35. McKay S, de Jongste JC, Saxena PR, Sharma HS. Angiotensin II induces hypertrophy of human airway smooth muscle cells: expression of transcription factors and transforming growth factor-β1. Am J Respir Cell Mol Biol 1998; 18: 823-33.
36. Panettieri RA, Murray RK, Eszterhs AJ, Bilgen G, Martin JG. Repeated allergen inhalations induce DNA synthesis in airway smooth muscle and epithelial cells in vivo. Am J Physiol Lung Cell Mol Physiol 1998; 274: L417-24.
37. Corrigan CJ, Brown PH, Barnes NC, et al. Glucocorticoid resistance in chronic asthma glucocorticoid pharmacokinetics glucocorticoid receptor characteristics, and inhibition of peripheral-blood T-cell proliferation by glucocorticoids in vitro. Am Rev Respir Dis 1991; 144: 1016-25.
38. Adcock IM, Lane SI, Brown CR, Peters MJ, Lee TH, Barnes PJ. Differences in binding of glucocorticoid receptor to DNA in steroid-resistant asthma. J Immunol 1995; 154: 3500-5.
39. Spector SL. Treatment of the unusually difficult asthmatic patients. Allergy Asthma Proc 1997; 18: 153-5.
40. Barnes PJ. Anti-Ig: antibody therapy for asthma. N Engl J Med 1999; 341: 2006-8.
41. Barnes PJ, Endothelins and pulmonary diseases. J Appl Physiol 1994; 77: 1051-9.
42. A receptor-mediated phenomenon. Br J Pharmacol 1996; 118: 191-7.
43. Burnouf C, Pruniaux MP. Recent advances in PDE4 inhibitors as immunoregulators and anti-inflammatory drugs. Curr Pharmaceutical Des 2002; 8: 1255-96.
44. Kohyama T, Liu XD, Zhu YK, et al. Phosphodiesterase inhibitor Cilomast inhibits fibroblasts-mediated collagen gel degradation induced by tumor necrosis factor-α. Am J Respir Cell Mol Biol 2002; 27: 487-94.